Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods

  60% confidence

• The Corporate Governance and Nominating Committee of the Board will review the proposed nominees in accordance with the Company's bylaws

  60% confidence

• The Seer Board of Directors will carefully review and consider the Proposal to determine the course of action that it believes is in the best interests of the Company and all Seer stockholders

  60% confidence

• Seer sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable

  60% confidence

Cited in these Via News reports

• FDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in Deals →